Selegiline, fluoxetine, and depression in Parkinson's disease
- 1 May 1995
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 10 (3) , 352
- https://doi.org/10.1002/mds.870100322
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegilineThe Lancet, 1993
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- Potential Fluoxetine—Selegiline InteractionAnnals of Pharmacotherapy, 1992
- The serotonin syndromeAmerican Journal of Psychiatry, 1991
- Specificity of affective and autonomic symptoms of depression in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- A Controlled Study of the Antidepressant Efficacy and Side Effects of ( — )-DeprenylArchives of General Psychiatry, 1989
- Depression in Parkinson's disease: a quantitative and qualitative analysis.Journal of Neurology, Neurosurgery & Psychiatry, 1986